ipamorelin administration CJC-1295/Ipamorelin Dosage: Dosing & Cycle Guide A panel of advisers to

JAMA 272:18451850 Bolesta S, Haber SL (2002) Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors

Pharm Res 39:1415

30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)

Proper handling and storage conditions help reduce degradation processes such as hydrolysis, oxidation, and peptide aggregation, supporting stability during short-term experimental use